NetworkNewsBreaks Archive - Page 2180 of 2262

WednesdayApr 26, 2017 12:03 pm

NetworkNewsBreaks – Lightwave Logic, Inc. (LWLG) Achieves Bandwidth Suitable for 25Gbps in Modulator Prototype

Shares of Lightwave Logic (OTCQB: LWLG) are up 5% in mid-day trade following the company’s news that it has achieved bandwidth suitable for 25Gbps data rates in an all-organic polymer ridge waveguide intensity modulator prototype, representing a significant improvement over its initial 10Gbps device modulator. The Mach-Zehnder design allows Lightwave to address 100Gbps using its polymer photonics integrated circuit technology platform. "We expect that the 25Gbps device will generate significant industry attention as we squarely address powerful, cost-effective miniaturized solutions for both today's 100Gbps, and future 400Gbps higher performance markets," Lightwave CEO Tom Zelibor stated in the news release. To…

WednesdayApr 26, 2017 12:01 pm

NetworkNewsBreaks – Finjan Holdings, Inc.’s (NASDAQ: FNJN) Finjan Mobile Subsidiary Partners with Avira to Extend Market Reach

Finjan Holdings (NASDAQ: FNJN) this morning said its Finjan Mobile subsidiary has entered into a partnership agreement with Avira, Inc. through which Avira will provide its Virtual Private Network (VPN) Platform for distribution and sale by Finjan Mobile as part of its VitalSecurity™ suite of product offerings. Additionally, the companies entered into a confidential cross-license under their respective patents. "As we work to build upon our suite of secured products, the partnership with Avira will allow us to reach a much broader customer base across multiple platforms. We are committed to offering a best-in-class suite of secure mobile applications and…

WednesdayApr 26, 2017 11:19 am

NetworkNewsBreaks – Bollente Companies, Inc. (BOLC) Targets $17B Tankless Water Heater Industry

Bollente Companies (OTC: BOLC), through its trutankless division, is strengthening its lead in the tankless water heater industry with an award-winning, energy saving solution that addresses a multi-billion dollar demand. “Globally, tankless water heater sales generated an estimated revenue of nearly $17 billion, according to Persistence Market Research (http://nnw.fm/83kBA), and they are projected to exceed well over $25 billion by 2024. This market segment represents just a small part of the global green building sector, which is currently outpacing overall U.S. construction growth and continues to double in size every three years. Smart appliances, including IoT devices in the home,…

WednesdayApr 26, 2017 10:05 am

NetworkNewsBreaks – Net Element’s (NASDAQ: NETE) PayOnline Introduces “Instant Credit” Feature

Mobile payment technology company Net Element, Inc. (NASDAQ: NETE), through its PayOnline subsidiary, this morning announced the launch of “Instant Credit,” a new feature that allows online merchants to sell goods and services on credit. Through this service, consumers will have the option to interact directly with integrated credit institutions to secure instant access to loans, giving merchants the means to achieve higher conversion rates at checkout and increase average ticket size. Industry research indicates that a large number of Russian consumers buy expensive goods and services on credit, but this payment option is only available on a small number…

TuesdayApr 25, 2017 4:04 pm

NetworkNewsBreaks – Player’s Network, Inc. (PNTV) Issues Update on WeedTV.com, Plans to Launch Beta

In a recent letter to shareholders, Player's Network (OTCQB: PNTV) issued an update on its WeedTV.com platform. The platform has been internally tested and the company said it expects it to have a beta launch in the near future. WeedTV.com will enable any business in the medicinal marijuana industry to create a personalized media network online. In the letter, the company explains that revenue will be generated through licensing of the software that creates and controls each of these personalized media networks. To date, the company has received an estimated $450,000 in product sponsorships from companies who have signed with…

TuesdayApr 25, 2017 3:14 pm

NetworkNewsBreaks – Catabasis Pharmaceuticals (NASDAQ: CATB) Reports Positive Functional Assessment Results in MoveDMD® Trial for Edasalonexent in DMD

Catabasis Pharmaceuticals (NASDAQ: CATB) this morning reported positive results in the MoveDMD trial across multiple functional assessments, which were recently presented at the American Academy of Neurology 69th Annual Meeting. Numerical improvements were seen in prespecified rate change analyses across five functional assessments in part B of the trial, which was designed to evaluate the potential of edasalonexent in the treatment of Duchenne muscular dystrophy (DMD). These results are consistent with the numerical improvements in the same functional assessments with edasalonexent compared to placebo after 12 weeks of edasalonexent treatment. Part C interim results are anticipated for the third quarter…

TuesdayApr 25, 2017 1:28 pm

NetworkNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Announces Engagement of NetworkNewsWire

India Globalization Capital, Inc. (NYSE MKT: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning announced its engagement of NetworkNewsWire (NNW) for corporate communications solutions. NNW is a multifaceted financial news and publishing company working to help public and private organizations find their voice and build market visibility by leveraging a rapidly expanding distribution network of more than 5,000 key syndication outlets. “We have an exciting pipeline of phytocannabinoid-based treatments based on our formulation for pain,” Ram Mukunda, CEO of IGC, stated in this morning’s news release. “As we move toward pre clinical and…

TuesdayApr 25, 2017 1:01 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on April 25, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: NMRD 17.14% – News: Completes development and testing of second-generation sugarBEAT® wireless skin patch CCAN 11.24% – News: Enters settlement agreement for potential sale of The Clinic Network Inc. assets CTIC 10.05% – News: Enters agreement with Servier to expand license and collaboration agreement CAPR 8.89% – News: Reports positive six-month results from HOPE clinical trial NIHD 7.37% – News: Appoints new CEO CAPC 7.27% – News: Increases Q1 2017 revenue expectations BNKL 7.14%…

TuesdayApr 25, 2017 1:01 pm

NetworkNewsBreaks – Galectin Therapeutics, Inc. (NASDAQ: GALT) Receives Decision to Grant From Japanese Patent Office for GR-MD-02 Composition of Matter Patent

Galectin Therapeutics (NASDAQ: GALT) this morning said it has received a decision from the Japanese Patent Office to grant its patent application for "Composition of Novel Carbohydrate Drug for Treatment of Human Diseases." Upon issuance, the patent will expand coverage of the company's lead compound, GR-MD-02, to Japan through 2032. "The allowance of these claims in Japan further strengthens the protection of the intellectual property behind our proprietary compound, GR-MD-02. This is especially important in Japan, which was recently declared the second most attractive drug market in the world," Galectin CEO and chief medical officer Peter G. Traber, M.D. stated…

TuesdayApr 25, 2017 11:45 am

NetworkNewsBreaks – Intellipharmaceutics International, Inc. (NASDAQ: IPCI) Leveraging Hypermatrix™ Technology to Address Key Pharmaceutical Markets

Intellipharmaceutics International, Inc. (NASDAQ: IPCI) is engaged in the research, development and commercialization of controlled-release and targeted pharmaceutical products. Leveraging its proprietary Hypermatrix™ technology, the company is focused on addressing two key niche markets, including difficult-to-produce controlled-release generic drugs (ANDA regulatory pathway) and improved current therapies through controlled-release (NDA regulatory pathway). Intellipharmaceutics' lead product is a generic of Focalin XR®, a mild central nervous system stimulant used to treat attention deficit hyperactivity disorder. This product is currently marketed in a variety of strengths by the company’s U.S. marketing partner, Par Pharmaceutical, Inc. Intellipharmaceutics’ development pipeline also includes its Rexista™ product…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsBreaks